<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: In situ hybridization (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e>) is an efficient tool for detecting chromosomal abnormalities in haemopoietic <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Structural and numerical changes typical of most pathological entities can be detected using chromosome-specific probes on interphase or metaphase cells by means of this technique </plain></SENT>
<SENT sid="2" pm="."><plain>PATIENTS AND METHODS: In this report we present chromosome analysis combining conventional cytogenetics with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e> in 121 patients affected with different haematological diseases </plain></SENT>
<SENT sid="3" pm="."><plain>We have studied 92 patients with B-<z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo> (B-CLPD), 11 <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), 17 <z:hpo ids='HP_0011009'>acute</z:hpo> nonlymphocytic <z:mpath ids='MPATH_336'>leukaemias</z:mpath> (ANLL), 1 <z:hpo ids='HP_0011009'>acute</z:hpo> lymphocytic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> and 1 aplastic <z:hpo ids='HP_0001903'>anaemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e> was carried out with two kind of <z:chebi fb="1" ids="15956">biotin</z:chebi>-labeled probes: a) 8 and 12 centromeric alpha satellite probes and b) whole painting chromosome (WPC) library probes from <z:hpo ids='HP_0000001'>all</z:hpo> the chromosomes except numbers 10, 16, 21, X and Y </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The cytogenetic analysis of B-CLPD has been hampered by several problems </plain></SENT>
<SENT sid="6" pm="."><plain>These leukaemic cells have very low spontaneous mitotic activity and the cell response to <z:chebi fb="0" ids="52290">mitogens</z:chebi> is often poor, unpredictable and variable </plain></SENT>
<SENT sid="7" pm="."><plain>Even so, an extra chromosome 12 (+ 12) is one of the most frequent abnormal karyotypes reported </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e> and chromosome 12 specific biotinylated alpha satellite DNA probe was applied in 84 patients with B-CLPD </plain></SENT>
<SENT sid="9" pm="."><plain>Among 50 patients with typical <z:hpo ids='HP_0011010'>chronic</z:hpo> lymphocytic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> (CLL) the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e> studies showed two signals of hybridization in the 50 cases </plain></SENT>
<SENT sid="10" pm="."><plain>By conventional cytogenetics 9 out of 18 atypical CLL showed chromosomal abnormalities and 7 of them <z:mp ids='MP_0004027'>trisomy</z:mp> 12 </plain></SENT>
<SENT sid="11" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e> detected <z:mp ids='MP_0004027'>trisomy</z:mp> 12 in 11 of these cases </plain></SENT>
<SENT sid="12" pm="."><plain><z:mp ids='MP_0004027'>Trisomy</z:mp> 8 is the most frequent karyotypic change in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and ANLL </plain></SENT>
<SENT sid="13" pm="."><plain>Cytogenetic results revealed a clear extra copy of chromosome 8 in 13 cases </plain></SENT>
<SENT sid="14" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> of these trisomic cases, the presence of <z:mp ids='MP_0004027'>trisomy</z:mp> 8 clone was confirmed by <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e> </plain></SENT>
<SENT sid="15" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e> revealed <z:mp ids='MP_0004027'>trisomy</z:mp> 8 not detected by conventional cytogenetics in 7 cases </plain></SENT>
<SENT sid="16" pm="."><plain>The yield of <z:mp ids='MP_0004027'>trisomy</z:mp> is much higher with the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e> technique than with conventional cytogenetics </plain></SENT>
<SENT sid="17" pm="."><plain>Finally, conventional cytogenetics combined with CISS (chromosomal in situ suppression) hybridization was performed in 15 patients affected with different haematological diseases showing structural aberrations, complex karyotypes or marker chromosomes </plain></SENT>
<SENT sid="18" pm="."><plain>CONCLUSIONS: Our results show that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e> can detect both numerical and structural chromosome changes with high specificity and reliability </plain></SENT>
<SENT sid="19" pm="."><plain>The fact that chromosome spreads of very poor quality can now be included in such analysis is the decisive advantage of this approach </plain></SENT>
</text></document>